Intravitreal bevacizumab for branch retinal vein occlusion [2]

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 1, 2007, Pages 118-119

  Spandau, Ulrich ^a,b,c   Wickenhäuser, Anne ^a,b   Rensch, Florian ^a,b   Jonas, Jost ^a,b  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; LETTER; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; VISUAL ACUITY;

EID: 33846430005     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00850.x     Document Type: Letter

References (5)

1. Branch Vein Occlusion Study Group (1984): Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98: 271-282.
2. Iturralde D, Spaide RF, Meyerle CB et.al. (2006): Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina 26: 279-284.
3. Jaissle GB, Ziemssen F, Petermeier K et.al. (2006): Bevacizumab for treatment of macular edema secondary to retinal vein occlusion [Bevacizumab zur Therapie des sekundären Makulaödems nach venösen Gefäßverschlüssen]. Ophthalmologe, 103: 471-475.
4. Rosenfeld PJ, Fung AE & Puliafito CA (2005): Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36: 336-339.
5. Spandau UH, Ihloff AK & Jonas JB (2006): Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 84: 555-556.